IBDEI0LN ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,9739,2)
;;=^5000360
;;^UTILITY(U,$J,358.3,9740,0)
;;=R63.0^^39^417^13
;;^UTILITY(U,$J,358.3,9740,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9740,1,3,0)
;;=3^Anorexia
;;^UTILITY(U,$J,358.3,9740,1,4,0)
;;=4^R63.0
;;^UTILITY(U,$J,358.3,9740,2)
;;=^7939
;;^UTILITY(U,$J,358.3,9741,0)
;;=R87.611^^39^417^2
;;^UTILITY(U,$J,358.3,9741,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9741,1,3,0)
;;=3^ASC-H
;;^UTILITY(U,$J,358.3,9741,1,4,0)
;;=4^R87.611
;;^UTILITY(U,$J,358.3,9741,2)
;;=^5019669
;;^UTILITY(U,$J,358.3,9742,0)
;;=R87.610^^39^417^3
;;^UTILITY(U,$J,358.3,9742,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9742,1,3,0)
;;=3^ASC-US
;;^UTILITY(U,$J,358.3,9742,1,4,0)
;;=4^R87.610
;;^UTILITY(U,$J,358.3,9742,2)
;;=^5019668
;;^UTILITY(U,$J,358.3,9743,0)
;;=Z98.82^^39^417^14
;;^UTILITY(U,$J,358.3,9743,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9743,1,3,0)
;;=3^Breast Implant Status
;;^UTILITY(U,$J,358.3,9743,1,4,0)
;;=4^Z98.82
;;^UTILITY(U,$J,358.3,9743,2)
;;=^5063747
;;^UTILITY(U,$J,358.3,9744,0)
;;=B37.3^^39^417^15
;;^UTILITY(U,$J,358.3,9744,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9744,1,3,0)
;;=3^Candidiasis of Vulva & Vagina
;;^UTILITY(U,$J,358.3,9744,1,4,0)
;;=4^B37.3
;;^UTILITY(U,$J,358.3,9744,2)
;;=^5000615
;;^UTILITY(U,$J,358.3,9745,0)
;;=D06.9^^39^417^16
;;^UTILITY(U,$J,358.3,9745,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9745,1,3,0)
;;=3^Carcinoma in Situ of Cervix,Unspec
;;^UTILITY(U,$J,358.3,9745,1,4,0)
;;=4^D06.9
;;^UTILITY(U,$J,358.3,9745,2)
;;=^5001941
;;^UTILITY(U,$J,358.3,9746,0)
;;=D06.0^^39^417^17
;;^UTILITY(U,$J,358.3,9746,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9746,1,3,0)
;;=3^Carcinoma in Situ of Endocervix
;;^UTILITY(U,$J,358.3,9746,1,4,0)
;;=4^D06.0
;;^UTILITY(U,$J,358.3,9746,2)
;;=^5001938
;;^UTILITY(U,$J,358.3,9747,0)
;;=D06.1^^39^417^18
;;^UTILITY(U,$J,358.3,9747,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9747,1,3,0)
;;=3^Carcinoma in Situ of Exocervix
;;^UTILITY(U,$J,358.3,9747,1,4,0)
;;=4^D06.1
;;^UTILITY(U,$J,358.3,9747,2)
;;=^5001939
;;^UTILITY(U,$J,358.3,9748,0)
;;=A56.02^^39^417^19
;;^UTILITY(U,$J,358.3,9748,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9748,1,3,0)
;;=3^Chlamydial Vulvovaginitis
;;^UTILITY(U,$J,358.3,9748,1,4,0)
;;=4^A56.02
;;^UTILITY(U,$J,358.3,9748,2)
;;=^5000340
;;^UTILITY(U,$J,358.3,9749,0)
;;=N81.12^^39^417^22
;;^UTILITY(U,$J,358.3,9749,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9749,1,3,0)
;;=3^Cystocele,Lateral
;;^UTILITY(U,$J,358.3,9749,1,4,0)
;;=4^N81.12
;;^UTILITY(U,$J,358.3,9749,2)
;;=^331535
;;^UTILITY(U,$J,358.3,9750,0)
;;=N81.11^^39^417^23
;;^UTILITY(U,$J,358.3,9750,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9750,1,3,0)
;;=3^Cystocele,Midline
;;^UTILITY(U,$J,358.3,9750,1,4,0)
;;=4^N81.11
;;^UTILITY(U,$J,358.3,9750,2)
;;=^331534
;;^UTILITY(U,$J,358.3,9751,0)
;;=N81.10^^39^417^24
;;^UTILITY(U,$J,358.3,9751,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9751,1,3,0)
;;=3^Cystocele,Unspec
;;^UTILITY(U,$J,358.3,9751,1,4,0)
;;=4^N81.10
;;^UTILITY(U,$J,358.3,9751,2)
;;=^5015838
;;^UTILITY(U,$J,358.3,9752,0)
;;=R87.614^^39^417^25
;;^UTILITY(U,$J,358.3,9752,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9752,1,3,0)
;;=3^Cytologic Evidence of Malig on Smear of Cervix
;;^UTILITY(U,$J,358.3,9752,1,4,0)
;;=4^R87.614
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0LN 3754 printed Apr 09, 2024@21:57:02 Page 2
IBDEI0LN ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,9739,2)
+2 ;;=^5000360
+3 ;;^UTILITY(U,$J,358.3,9740,0)
+4 ;;=R63.0^^39^417^13
+5 ;;^UTILITY(U,$J,358.3,9740,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,9740,1,3,0)
+8 ;;=3^Anorexia
+9 ;;^UTILITY(U,$J,358.3,9740,1,4,0)
+10 ;;=4^R63.0
+11 ;;^UTILITY(U,$J,358.3,9740,2)
+12 ;;=^7939
+13 ;;^UTILITY(U,$J,358.3,9741,0)
+14 ;;=R87.611^^39^417^2
+15 ;;^UTILITY(U,$J,358.3,9741,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,9741,1,3,0)
+18 ;;=3^ASC-H
+19 ;;^UTILITY(U,$J,358.3,9741,1,4,0)
+20 ;;=4^R87.611
+21 ;;^UTILITY(U,$J,358.3,9741,2)
+22 ;;=^5019669
+23 ;;^UTILITY(U,$J,358.3,9742,0)
+24 ;;=R87.610^^39^417^3
+25 ;;^UTILITY(U,$J,358.3,9742,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,9742,1,3,0)
+28 ;;=3^ASC-US
+29 ;;^UTILITY(U,$J,358.3,9742,1,4,0)
+30 ;;=4^R87.610
+31 ;;^UTILITY(U,$J,358.3,9742,2)
+32 ;;=^5019668
+33 ;;^UTILITY(U,$J,358.3,9743,0)
+34 ;;=Z98.82^^39^417^14
+35 ;;^UTILITY(U,$J,358.3,9743,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,9743,1,3,0)
+38 ;;=3^Breast Implant Status
+39 ;;^UTILITY(U,$J,358.3,9743,1,4,0)
+40 ;;=4^Z98.82
+41 ;;^UTILITY(U,$J,358.3,9743,2)
+42 ;;=^5063747
+43 ;;^UTILITY(U,$J,358.3,9744,0)
+44 ;;=B37.3^^39^417^15
+45 ;;^UTILITY(U,$J,358.3,9744,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,9744,1,3,0)
+48 ;;=3^Candidiasis of Vulva & Vagina
+49 ;;^UTILITY(U,$J,358.3,9744,1,4,0)
+50 ;;=4^B37.3
+51 ;;^UTILITY(U,$J,358.3,9744,2)
+52 ;;=^5000615
+53 ;;^UTILITY(U,$J,358.3,9745,0)
+54 ;;=D06.9^^39^417^16
+55 ;;^UTILITY(U,$J,358.3,9745,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,9745,1,3,0)
+58 ;;=3^Carcinoma in Situ of Cervix,Unspec
+59 ;;^UTILITY(U,$J,358.3,9745,1,4,0)
+60 ;;=4^D06.9
+61 ;;^UTILITY(U,$J,358.3,9745,2)
+62 ;;=^5001941
+63 ;;^UTILITY(U,$J,358.3,9746,0)
+64 ;;=D06.0^^39^417^17
+65 ;;^UTILITY(U,$J,358.3,9746,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,9746,1,3,0)
+68 ;;=3^Carcinoma in Situ of Endocervix
+69 ;;^UTILITY(U,$J,358.3,9746,1,4,0)
+70 ;;=4^D06.0
+71 ;;^UTILITY(U,$J,358.3,9746,2)
+72 ;;=^5001938
+73 ;;^UTILITY(U,$J,358.3,9747,0)
+74 ;;=D06.1^^39^417^18
+75 ;;^UTILITY(U,$J,358.3,9747,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,9747,1,3,0)
+78 ;;=3^Carcinoma in Situ of Exocervix
+79 ;;^UTILITY(U,$J,358.3,9747,1,4,0)
+80 ;;=4^D06.1
+81 ;;^UTILITY(U,$J,358.3,9747,2)
+82 ;;=^5001939
+83 ;;^UTILITY(U,$J,358.3,9748,0)
+84 ;;=A56.02^^39^417^19
+85 ;;^UTILITY(U,$J,358.3,9748,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,9748,1,3,0)
+88 ;;=3^Chlamydial Vulvovaginitis
+89 ;;^UTILITY(U,$J,358.3,9748,1,4,0)
+90 ;;=4^A56.02
+91 ;;^UTILITY(U,$J,358.3,9748,2)
+92 ;;=^5000340
+93 ;;^UTILITY(U,$J,358.3,9749,0)
+94 ;;=N81.12^^39^417^22
+95 ;;^UTILITY(U,$J,358.3,9749,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,9749,1,3,0)
+98 ;;=3^Cystocele,Lateral
+99 ;;^UTILITY(U,$J,358.3,9749,1,4,0)
+100 ;;=4^N81.12
+101 ;;^UTILITY(U,$J,358.3,9749,2)
+102 ;;=^331535
+103 ;;^UTILITY(U,$J,358.3,9750,0)
+104 ;;=N81.11^^39^417^23
+105 ;;^UTILITY(U,$J,358.3,9750,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,9750,1,3,0)
+108 ;;=3^Cystocele,Midline
+109 ;;^UTILITY(U,$J,358.3,9750,1,4,0)
+110 ;;=4^N81.11
+111 ;;^UTILITY(U,$J,358.3,9750,2)
+112 ;;=^331534
+113 ;;^UTILITY(U,$J,358.3,9751,0)
+114 ;;=N81.10^^39^417^24
+115 ;;^UTILITY(U,$J,358.3,9751,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,9751,1,3,0)
+118 ;;=3^Cystocele,Unspec
+119 ;;^UTILITY(U,$J,358.3,9751,1,4,0)
+120 ;;=4^N81.10
+121 ;;^UTILITY(U,$J,358.3,9751,2)
+122 ;;=^5015838
+123 ;;^UTILITY(U,$J,358.3,9752,0)
+124 ;;=R87.614^^39^417^25
+125 ;;^UTILITY(U,$J,358.3,9752,1,0)
+126 ;;=^358.31IA^4^2
+127 ;;^UTILITY(U,$J,358.3,9752,1,3,0)
+128 ;;=3^Cytologic Evidence of Malig on Smear of Cervix
+129 ;;^UTILITY(U,$J,358.3,9752,1,4,0)
+130 ;;=4^R87.614
